UNICEF Digital Technology’s Post

In today’s global health landscape, the leadership from African countries in public-private partnerships is crucial for driving effective innovation to reach the patients in need. On May 27th, in concomitance with the #WorldHealthAssembly, a strategic event organized by Merck together with the Cercle Diplomatique De Genève, brought together key stakeholders from international organizations, public and private sectors, and distinguished countries’ representatives. The event drew attention on critical aspects, including the burden of neglected tropical diseases, towards promoting local sustainability and self-sufficiency for addressing local public health challenges. The Pediatric Praziquantel Consortium program showed a model that led to the development of a new pediatric treatment option for preschoolers with #schistosomiasis. Beyond creating local clinical excellence and building local manufacturing capacity, the program also showed the need for close collaboration with and engagement from the African countries to enable sustainable and equitable accessibility to health innovations. Read more: https://lnkd.in/e9iFKVFi #GlobalHealth #HealthEquity #EndNTDs #Sustainability Karim Bendhaou Jutta Reinhard-Rupp Beatrice Greco Johannes Waltz Marc Escudié Isaac Chikwanha Dr. Sultani Matendechero ‘ndc’(K) Emira Bahri Merck Healthcare IFPMA The END Fund World Health Organization Uniting to Combat Neglected Tropical Diseases Global Health Innovative Technology (GHIT) Fund

AIGHD Executive Director Anna Vassall recently co-hosted a panel together with Antoni Plasencia from Barcelona Institute for Global Health (ISGlobal) at #ECTMIH2023's morning plenary on the 22nd of November. We have a Tweet thread which covered the most essential items discussed during the plenary but in summary: 1. Dr. Jan Paehler discussed the EU's new Global Health strategy and focused on the growth of the Global Health EDCTP3 programmes in both funding and scope. This is part of the European Commission's commitments to the 'Health-in-all-policies' approach. 2. During the panel discussion, Lisa Goerlitz from the Deutsche Stiftung Weltbevoelkerung (DSW) brought up the EU's new pharmaceutical strategy and how it crucially misses a global health component and perspective. She also mentions the importance of EU citizens to contact their MEPs if they wish to be better represented in the EU's Global Health Strategy. 3. Dr. Constance Assohou-Luty from the World Health Organization discussed the unique alignment between the European Union, African Union, and the World Health Organization to promote Africa's New Public Health Order. In particular, she discusses the push to develop local capacity in medicine production and to develop the local workforce. 4. The audience also questioned the gap in HORIZON Europe programming when trying to address Planetary Health but Dr. Jan specified that HORIZON is structured in a manner where projects focused on a specific aspect of Global Health are brought together thematically. These processes help build a broad network on which we can base effects and interventions for #planetaryhealth. We hope you enjoyed reading our short coverage of this year's #ECTMIH2023 morning plenary session on the EU's new Global Health Strategy.

Clinical trials are the cornerstone of high-quality health research towards the development of products that serve global public health needs. This #ClinicalTrialsDay, we exhort health product developers to align their product development pipelines with public health priorities.   Through the Emerging Technologies, Research Prioritisation and Support Unit of the WHO, we work to support and optimize R&D for health products in various ways:­ 👩💻 ICTRP is the largest repository of data on clinical trials happening around the world https://lnkd.in/eTrk7uNs 📈 We analyse what trials are happening where and make this available for everyone in the global observatory on health R&D https://lnkd.in/eUD8uCwW 👩🔬 Data and experts come together to set global research priorities for the greatest public health impact https://lnkd.in/ejyE9rJW 💊 We support Target Product Profiles, the characteristics of specific health products needed https://lnkd.in/eDqze9a8 💉 And we identify the research evidence needed, including from clinical trials, to develop strong policy recommendations to improve public health. https://lnkd.in/e4kecw77 I was once honored to be part of a clinical trial for anti-malarial treatments in the Solomon Islands. This photo is from the thousands upon thousands of blood spots collected from participants. This clinical trials day we shout our support to clinical triallists gathering high quality evidence around the world on which we can build better health for all, and to the constant work to improve clinical trials by WHO and beyond Anna Laura Ross, Ghassan Karam, MSc, Mercedes Perez Gonzalez, Amina Haouala, Vasee Moorthy, Wei Zhang

👉 Missed the launch of our Cancer Thematic Innovation Ecosystem with ECHAlliance - The Global Health Connector, no worries here are some key highlights 🤗 🔹 🇷🇴 The Arges Living Lab is making waves in bridging urban-rural digital divides, paving the way for equitable access to healthcare resources says Marius Geanta, MD 🔹 🌎 In Latin America and the Caribbean, we must advocate for informed decision-making, we're emphasizing the importance of directing individuals towards credible health information sources says Carolina Espina, PhD, MPH and Ariadna Feliu Josa, BSc, BA, MPH, PhD from IARC - International Agency for Research on Cancer / World Health Organization 🔹 🇳🇬#Nigeria's impactful policy interventions, including increased tobacco taxes and dynamic public awareness campaigns, are driving significant strides in cancer prevention! Great examples shared by Hannatu Ayuba 🔹 Berna Koçar's impassioned call to empower vulnerable communities in Turkey underscores a commitment to inclusive healthcare solutions 🇹🇷 🔹 Ashish Basuray, PhD's insights shed light on the transformative power of patient empowerment in shaping the future of healthcare in the US. With 50% of the population expected to experience cancer, what can we do to #ActOnNCDs Stay tuned for more updates 💪 #CancerPrevention #Healthcare #PublicHealth #HealthEquity

CoMeCT unites expertise through a strong international consortium to better coordinate clinical research efforts. 🔍 Building on European efforts initially developed during the COVID-19 crisis, this consortium will endeavour to unite key stakeholders to continue to shape the European response to any future pandemic / epidemic. 🚀 Beyond the seven consortium members, the project includes strategic European adapative platform trials and cohort studies, as well as other key stakeholders. Learn more about our solutions to coordinate studies for better healthcare on https://comectproject.org/ 🤝 #Coordination #ClinicalResearch #InfectiousDiseases #CoMeCT ANRS Maladies infectieuses émergentes Ecraid ECRIN (European Clinical Research Infrastructure Network) Norwegian Institute of Public Health Penta Foundation - Child Health Research ID-CARE UNIVR Università degli Studi di Verona VACCELERATE_EU European Health and Digital Executive Agency (HaDEA)

✋ Join us for a Quadripartite webinar on #behaviouralinsights and change to address #antimicrobialresistance at One Health interfaces! 📆 When: 06 March 2024 from12h to 13:30 CET ❓ How: Register here to join: https://lnkd.in/d8DsVjMV The Quadripartite organizations #FAO #UNEP #WHO #WOAH have developed the #onehealth Priority Research Agenda for AMR (AMR-OHPRA), as a joint initiative to catalyze scientific interest and financial investments for AMR priority research across sectors for countries and funding bodies. 🔬 The research agenda serves as a guide to prevent and mitigate AMR within the One Health approach that will help policymakers, researchers, and a multidisciplinary scientific community to work together on solutions. The webinar includes a panel discussion on the challenges and opportunities that this Agenda brings to the One Health community and how this agenda can attract and motivate donors, the scientific community, and governments to support research addressing the specific areas identified for the #behaviouralinsights and change pillar. Jorge Matheu, Elisabeth Erlacher-Vindel, Aitziber Echeverria 

Innovation and thinking differently…. 👍 Matters to #patientaccess We presented our poster mapping alternative access solutions in our Central South East Europe region (25 countries) to increase the number of options to gain patient access 🇪🇺 Delivers strong cross country collaboration Alexander Wendt and myself on behalf of Hrvojka Kostelac Zeljka Vukelic and Sander Mac-Lean with a special thanks to all of our Access colleagues collaborated in #agile manners, quickly delivering rich insights and valuable results 🗣 Resulted in great insights, discussions and learnings We had fun and enjoyed presenting these results as it delivered new ideas (coming from other countries) and validated some ideas as well (countries in our region that were present) 💯Allows us to collaborate together with our stakeholders By understanding each other’s perspectives we can truly #collaborate and overcoming challenges or uncertainties that rare diseases might bring with them. #Earlyengagement of the involved stakeholders is one our our call to actions in our ISPOR—The Professional Society for Health Economics and Outcomes Research poster.

✋ Join us for a Quadripartite webinar organized in collaboration with the Global AMR R&D Hub to address #antimicrobialresistance at One Health interfaces! 📆 When: 18 July 2024 from12.30h to 14:00 CEST ❓ How: Register here to join: https://lnkd.in/dpGSSaSg The Quadripartite organizations #FAO #UNEP #WHO #WOAH have developed the #onehealth Priority Research Agenda for AMR (AMR-OHPRA), as a joint initiative to catalyze scientific interest and financial investments for AMR priority research across sectors for countries and funding bodies. 🔬 The research agenda serves as a guide to prevent and mitigate AMR within the One Health approach that will help policymakers, researchers, and a multidisciplinary scientific community to work together on solutions. The webinar will focus on the Opportunities to foster the implementation of the One Health Priority Research Agenda on AMR, and will include a panel discussion and an interactive Q&A session with participants on the opportunities to join forces, explore best ways for the implementation and propose ways to follow up progress. Jorge Matheu Elisabeth Erlacher-Vindel, Aitziber Echeverria Lesley Ogilvie Ralf Sudbrak

✋ Join us today for a Quadripartite webinar on Interventions to address #antimicrobialresistance at One Health interfaces! 📆 When: 07 February 2024 from12h to 13:30 CET ❓ How: Register here to join:  https://lnkd.in/d2QsNqhz The Quadripartite organizations (#FAO, #UNEP, #WHO #WOAH) have developed the #onehealth Priority Research Agenda for AMR (AMR-OHPRA), as a joint initiative to catalyze scientific interest and financial investments for AMR priority research across sectors for countries and funding bodies. 🔬 The research agenda serves as a guide to prevent and mitigate AMR within the One Health approach that will help policymakers, researchers, and a multidisciplinary scientific community to work together on solutions.    The webinar includes a panel discussion on the challenges and opportunities that this Agenda brings to the One Health community and how this agenda can attract and motivate donors, the scientific community, and governments to support research addressing the specific areas identified for the Interventions pillar. Jorge Matheu , Elisabeth Erlacher-Vindel, Aitziber Echeverria

We are thrilled to announce our latest journal publication, now available in JMIR Publications's Journal of Medical Internet Research: “Tanzania’s and Germany’s Digital Health Strategies and Their Consistency With the World Health Organization’s Global Strategy on Digital Health 2020-2025: Comparative Policy Analysis”. This research provides a comparative analysis of Tanzania’s and Germany's digital health strategies in line with the World Health Organization's Global Strategy on Digital Health 2020-2025.  We examined the alignment of these national strategies with global health objectives, highlighting areas of strength and opportunities for further development. As we navigate the complexities of digital health in the global landscape, this publication offers valuable insights into creating more inclusive, comprehensive digital health strategies. It underlines the critical need for regular updates and context-specific adaptations to effectively integrate emerging technologies in health care systems worldwide. This work is a collaboration between Felix Holl, FAMIA, Jennifer Kircher, and Walter Swoboda from the DigiHealth Institute with Felix Sukums from MUHAS Digital Health and Innovation Alliance and Attila Hertelendy, Ph.D. from Florida International University. 🔍 Dive into our findings and explore how national digital health strategies can better align with global health guidelines to enhance health care delivery across borders. Your thoughts and discussions on this are highly welcomed! Read the full publication here: https://lnkd.in/e3-Px5vd #DigitalHealth #GlobalHealth #PublicHealth #Innovation #DigiHealthInstitute #Research #Collaboration